Get started
Award

CL-2018-06-001

Funded outputs count: 10
Funder award ID: CL-2018-06-001
OpenAlex ID: G2210184154
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
2022 · Oskar Wysocki, Cong Zhou, et al. · Cancers · 2
PDF
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
2022 · Cátia Monteiro, Lauritz Miarka, et al. · Nature Medicine · 85
PDF
Circulating Tumour DNA in Melanoma—Clinic Ready?
2022 · Ann Tivey, Fiona Britton, et al. · Current Oncology Reports · 33
PDF
Patient Engagement in Melanoma Research: From Bench to Bedside
2021 · Ann Tivey, Prerana Huddar, et al. · Future Oncology · 8
Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort
2021 · Talvinder Bhogal, Umair T. Khan, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 27
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome
2021 · R.J. Lee, O. Wysocki, et al. · ESMO Open · 18
PDF
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
2020 · Lennard Y W Lee, Jean-Baptiste Cazier, et al. · The Lancet Oncology · 574
PDF
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
2020 · Lennard YW Lee, Jean-Baptiste Cazier, et al. · The Lancet · 1,102
PDF
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance
2020 · Jose L. Orgaz, Eva Crosas-Molist, et al. · Cancer Cell · 154
PDF
Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma
2020 · Rebecca Jane. Lee, Garima Khandelwal, et al. · ESMO Open · 6
PDF
Year
Topic